“…In ALS, cortical thinning and subcortical changes have been related to disease progression, putting forward these changes as a biomarker of ALS (Agosta et al, 2012, Mezzapesa et al, 2013, Turner and Verstraete, 2015, Verstraete et al, 2012, Walhout et al, 2015, Westeneng et al, 2015). For this reason, cortical thickness has been used as an alternative imaging metric to separate patients from controls, reaching accuracies ranging from 60 to 75% (Ahmed et al, 2015, Foland-Ross et al, 2015, Greenstein et al, 2012, Lerch et al, 2008). Notwithstanding the importance of exploring classification approaches to distinguish between patients and controls, predicting disease course , i.e.…”